Chitosan Nanoparticles as Oral Drug Carriers

被引:24
|
作者
Rodrigo Guadarrama-Escobar, Omar [1 ]
Serrano-Castaneda, Pablo [1 ]
Anguiano-Almazan, Ericka [1 ]
Vazquez-Duran, Alma [2 ]
Concepcion Pena-Juarez, Ma. [1 ]
Vera-Graziano, Ricardo [3 ]
Isabel Morales-Florido, Miriam [1 ,4 ]
Rodriguez-Perez, Betsabe [5 ]
Marlen Rodriguez-Cruz, Isabel [6 ]
Esteban Miranda-Calderon, Jorge [4 ]
Juan Escobar-Chavez, Jose [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria Lab 12, Carretera Cuautitlan Teoloyucan,Km 2-5 San Sebast, Cuautitlan 54714, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria L14 Ciencia & Te, Mexico City 54714, Estado de Mexic, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Invest Mat, Apartado Postal 70-360, Mexico City 04510, Mexico
[4] Univ Autonoma Metropolitana, Dept Sistemas Biol, Lab Farm Mol & Liberac Controlada, Xochimilco 04960, Mexico
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Lab Serv Anal Propoleos LASAP, Unidad Invest Multidisciplinaria UIM, Cuautitlan 54714, Mexico
[6] Hosp Reg Alta Especial Zumpango, Unidad Ensenanza & Invest, Carretera Zumpango Jilotzingo 400,2a Secc, Zumpango 55600, Mexico
关键词
chitosan; chitosan nanoparticles; oral administration; IN-VITRO; POLYMERIC NANOPARTICLES; GOLD NANOPARTICLES; DELIVERY; RELEASE; CANCER; BIOAVAILABILITY; PEPTIDES; TOXICITY; SYSTEM;
D O I
10.3390/ijms24054289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of nanoparticles as drug delivery systems has increased in importance in the last decades. Despite the disadvantages of difficulty swallowing, gastric irritation, low solubility, and poor bioavailability, oral administration stands out as the most widely used route for therapeutic treatments, though it may not always be the most effective route. The effect of the first hepatic pass is one of the primary challenges that drugs must overcome to carry out their therapeutic effect. For these reasons, controlled-release systems based on nanoparticles synthesized from biodegradable natural polymers have been reported to be very efficient in enhancing oral delivery in multiple studies. Chitosan has been shown to have an extensive variability of properties and roles in the pharmaceutical and health fields; of its most important properties are the ability to encapsulate and transport drugs within the body and enhance the drug interaction with the target cells, which improves the efficacy of the encapsulated drugs. The physicochemical properties of chitosan give it the ability to form nanoparticles through multiple mechanisms, which will be addressed in this article. The present review article focuses on highlighting the applications of chitosan nanoparticles for oral drug delivery.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Synthesis and characterization of fluorescent chitosan-ZnSe/ZnS nanoparticles for potential drug carriers
    Li, Yeping
    Xu, Jingbo
    Xu, Yun
    Huang, Liying
    Wang, Junli
    Cheng, Xiaonong
    RSC ADVANCES, 2015, 5 (49) : 38810 - 38817
  • [32] Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors
    Okur, Neslihan Ustundag
    Siafaka, Panoraia, I
    Gokce, Evren Homan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021, 22 (07) : 892 - 905
  • [33] Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers
    Liu, Ya
    Kong, Ming
    Feng, Chao
    Yang, Kui Kun
    Li, Yang
    Su, Jing
    Cheng, Xiao Jie
    Park, Hyun Jin
    Chen, Xi Guang
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 103 : 345 - 353
  • [34] Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery
    Nasirizadeh, Samira
    Malaekeh-Nikouei, Bizhan
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [35] Micro and nanoparticles as drug carriers
    Leucuta, SE
    NBC RISKS: CURRENT CAPABILITIES AND FUTURE PERSPECTIVES FOR PROTECTION, 1999, 25 : 411 - 439
  • [36] NANOPARTICLES AS DRUG CARRIERS IN OPHTHALMOLOGY
    HARMIA, T
    SPEISER, P
    KREUTER, J
    PHARMACEUTICA ACTA HELVETIAE, 1987, 62 (12): : 322 - 331
  • [37] Preparation and optimisation of PMAA-Chitosan-PEG nanoparticles for oral drug delivery
    Pawar, H.
    Douroumis, D.
    Boateng, J. S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1463 - 1464
  • [38] Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery
    Pawar, Harshavardhan
    Douroumis, Dionysios
    Boateng, Joshua S.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 90 : 102 - 108
  • [39] Chitosan graft copolymer nanoparticles for oral protein drug delivery: Preparation and characterization
    Qian, Feng
    Cui, Fuying
    Ding, Jieying
    Tang, Cui
    Yin, Chunhua
    BIOMACROMOLECULES, 2006, 7 (10) : 2722 - 2727
  • [40] Oral drug delivery using a polymeric nanocarrier: chitosan nanoparticles in the delivery of rifampicin
    Ghosh, Ria
    Mondal, Susmita
    Mukherjee, Dipanjan
    Adhikari, Aniruddha
    Ahmed, Saleh A.
    Alsantali, Reem, I
    Khder, Abdelrahman S.
    Altass, Hatem M.
    Moussa, Ziad
    Das, Ranjan
    Bhattacharyya, Maitree
    Pal, Samir Kumar
    MATERIALS ADVANCES, 2022, 3 (11): : 4622 - 4628